Literature DB >> 2494306

Continuous low-dose infusion of fluorouracil: is the benefit worth the cost?

J S Macdonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2494306     DOI： 10.1200/JCO.1989.7.4.412

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

Review 2.  Drug treatment of colorectal cancer. Current status.

Authors:  L Saltz
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 3.  First-line treatment strategies to improve survival in patients with advanced colorectal cancer.

Authors:  Sharlene Gill; Richard M Goldberg
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Bioavailability and feasibility of subcutaneous 5-fluorouracil.

Authors:  M M Borner; J Kneer; C Crevoisier; K W Brunner; T Cerny
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.